205 results on '"Mates, Martin"'
Search Results
2. Evaluation of the severity of right to left shunt in PFO patients after systemic embolism (MEASURE-PFO study). Design of the study
3. 1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO Collaboration
4. Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry)
5. The accuracy of detailed analysis of optical coherence tomography in detection of plaque lipid content: dual-imaging study with optical coherence tomography and near-infrared spectroscopy.
6. 1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration
7. Pre-Angioplasty Instantaneous Wave-Free Ratio Pullback Predicts Hemodynamic Outcome In Humans With Coronary Artery Disease: Primary Results of the International Multicenter iFR GRADIENT Registry
8. Evaluation of the severity of right-to-left shunt in PFO patients after systemic embolism (MEASURE-PFO study): Study design.
9. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Summary of the document prepared by the Czech Society of Cardiology
10. Czech TAVI registry – Hospital outcome
11. Management of low-gradient aortic stenosis
12. Study Design of the Graft Patency After FFR-Guided Versus Angiography-Guided CABG Trial (GRAFFITI)
13. Percutaneous closure of left atrial appendage for stroke prevention
14. The effect of early treatment by cerivastatin on the serum level of C-reactive protein, interleukin-6, and interleukin-8 in the patients with unstable angina and non-Q-wave myocardial infarction
15. The concept of functional revascularization
16. Fractional Flow Reserve Versus Instantaneous Wave‐Free Ratio in Assessment of Lesion Hemodynamic Significance and Explanation of their Discrepancies. International, Multicenter and Prospective Trial: The FiGARO Study
17. Long-term follow-up of a patient undergoing interatrial shunt device implantation for treatment of heart failure with a preserved ejection fraction
18. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Summary of the document prepared by the Working Group Valvular and Congenital Heart Defects in Adulthood of the Czech Society of Cardiology and the Czech Society of Cardiovascular Surgery of ČLS JEP
19. Correlation of lipoprotein(a) with the extent of coronary artery disease in patients with established coronary atherosclerosis: gender differences
20. Surgical ablation of the right greater splanchnic nerve for the treatment of heart failure with preserved ejection fraction: first‐in‐human clinical trial
21. Real-time use of instantaneous wave–free ratio: Results of the ADVISE in-practice: An international, multicenter evaluation of instantaneous wave–free ratio in clinical practice
22. Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure
23. (2020 ESC Guidelines for the management of adult congenital heart disease. Summary of the document prepared by the Czech Society of Cardiology)
24. Changes in surgical revascularization strategy after fractional flow reserve
25. Administration of cangrelor after coronary intervention immediately following minimally invasive cardiac surgery procedure
26. 1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry
27. The effect of early treatment by cerivastatin on the serum level of C-reactive protein, interleukin-6, and interleukin-8 in patients with unstable angina and non-Q-wave myocadial infarction
28. Role of transthoracic echocardiography in the detection of atrial septal aneurysm and intracardial shunts of PFO type in ambulatory practice
29. (Working in the cathlab during COVID-19 pandemic)
30. Transcatheter closure of patent foramen ovale - position paper of Czech association of interventional cardiology, Czech neurological society and Czech association of cardiac imaging of Czech society of cardiology
31. Development of percutaneous coronary interventions in the Czech Republic in 2005-2018. Results of the National Registry of Cardiovascular Interventions
32. Allergic reactions after ASD/PFO occluder implantation
33. Doporučené postupy ESC pro diagnózu a léčbu chronických koronárních syndromů, 2019.Souhrn dokumentu vypracovaný Českou kardiologickou společností
34. 1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaboration
35. Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting: the GRAFFITI trial
36. Fabry Disease: Percutaneous Transluminal Septal Myocardial Ablation Markedly Improved Symptomatic Left Ventricular Hypertrophy and Outflow Tract Obstruction in a Classically Affected Male
37. Corrigendum to “Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-year final clinical outcomes from the MASCOT post-marketing registry” [Int. J. Cardiol. 283 (2019) 67–72]
38. 2018 ESC/EACTS Guidelines on myocardial revascularization. Summary of the document prepared by the Czech Society of Cardiology, Czech Interventional Cardiology Association, Czech Society for Cardiovascular Surgery of CLS JEP
39. Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry
40. Endothelial dysfunction assessed by digital tonometry and discrepancy between fraction flow reserve and instantaneous wave free ratio
41. Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)
42. One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration.
43. Sex differences in 1‐year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration.
44. Transfemoral implantation of CoreValve Evolut R in patient with functionally bicuspid aortic valve
45. Five-Year Outcomes with PCI Guided by Fractional Flow Reserve
46. Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]
47. Pre-Angioplasty Instantaneous Wave-Free Ratio Pullback Predicts Hemodynamic Outcome In Humans With Coronary Artery Disease: Primary Results of the International Multicenter iFR GRADIENT Registry
48. Endothelial dysfunction assessed by digital tonometry and discrepancy between fraction flow reserve and instantaneous wave free ratio.
49. Odborné stanovisko pro uzávěr otevřeného foramen ovale (PFO).
50. Vývoj perkutánních koronárních intervencí v České republice v letech 2005-2018: Výsledky Národního registru kardiovaskulárních intervencí.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.